Recurrent pleomorphic dermal sarcoma of the temporal bone: Case report and literature review

[1]  A. Quaas,et al.  Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas , 2016, Oncotarget.

[2]  J. Tardío,et al.  Pleomorphic dermal sarcoma: a more aggressive neoplasm than previously estimated , 2016, Journal of cutaneous pathology.

[3]  D. Schadendorf,et al.  TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas , 2014, Modern Pathology.

[4]  T. Brenn.  Pleomorphic Dermal Neoplasms: A Review , 2014, Advances in anatomic pathology.

[5]  P. Casali,et al.  Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  J. Browne,et al.  Malignant fibrous histiocytoma of the head and neck: a case series. , 2013, American journal of otolaryngology.

[7]  C. D'Arrigo,et al.  Atypical fibroxanthoma--a retrospective immunohistochemical study of 42 cases. , 2012, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[8]  T. Brenn,et al.  Pleomorphic Dermal Sarcoma: Adverse Histologic Features Predict Aggressive Behavior and Allow Distinction From Atypical Fibroxanthoma , 2012, The American journal of surgical pathology.

[9]  R. Gónzalez-Gónzalez,et al.  Prognostic factors and treatment strategies for adult head and neck soft tissue sarcoma. , 2012, International journal of oral and maxillofacial surgery.

[10]  J. Davidson,et al.  Atypical fibroxanthoma: Clinicopathologic determinants for recurrence and implications for surgical management , 2012, Journal of surgical oncology.

[11]  John S. Davidson BSc,et al.  Atypical fibroxanthoma: Clinicopathologic determinants for recurrence and implications for surgical management , 2011 .

[12]  A. Weaver,et al.  More Than 2 Decades of Treating Atypical Fibroxanthoma at Mayo Clinic: What Have We Learned From 91 Patients? , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[13]  V. Ilankovan,et al.  Malignant fibrous histiocytoma: outcome of tumours in the head and neck compared with those in the trunk and extremities. , 2006, The British journal of oral & maxillofacial surgery.

[14]  D. Weedon,et al.  Atypical fibroxanthoma: A clinicopathological study of 89 cases , 2005, The Australasian journal of dermatology.

[15]  R. Roenigk,et al.  A Comparison of Mohs Micrographic Surgery and Wide Excision for the Treatment of Atypical Fibroxanthoma , 1997, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[16]  T. Calcaterra,et al.  Sarcomas of the head and neck. Prognostic factors and treatment strategies , 1992, Cancer.

[17]  L. Barnes,et al.  Malignant fibrous histiocytoma of the head and neck. A report of 12 cases. , 1988, Archives of otolaryngology--head & neck surgery.

[18]  D. Fretzin,et al.  Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases , 1973, Cancer.